Skip to Content

Integra Lifesciences Holdings Corp IART

Morningstar Rating
$28.68 −2.95 (9.33%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IART is trading within a range we consider fairly valued.
Price
$28.82
Fair Value
$39.53
Uncertainty
High
1-Star Price
$95.89
5-Star Price
$89.47
Economic Moat
Dhh
Capital Allocation
Nvymvbgz
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IART is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$31.63
Day Range
$27.8531.72
52-Week Range
$27.8559.10
Bid/Ask
$27.61 / $41.85
Market Cap
$2.25 Bil
Volume/Avg
2.9 Mil / 747,705

Key Statistics

Price/Earnings (Normalized)
9.25
Price/Sales
1.49
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
11.06%

Company Profile

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
3,946

Comparables

Valuation

Metric
IART
CNMD
ZIMV
Price/Earnings (Normalized)
9.2522.459.61
Price/Book Value
1.412.861.04
Price/Sales
1.491.960.91
Price/Cash Flow
10.4014.8212.19
Price/Earnings
IART
CNMD
ZIMV

Financial Strength

Metric
IART
CNMD
ZIMV
Quick Ratio
1.850.860.84
Current Ratio
3.451.982.78
Interest Coverage
2.243.03−1.51
Quick Ratio
IART
CNMD
ZIMV

Profitability

Metric
IART
CNMD
ZIMV
Return on Assets (Normalized)
6.54%4.68%14.12%
Return on Equity (Normalized)
14.87%13.85%31.63%
Return on Invested Capital (Normalized)
8.36%7.73%18.79%
Return on Assets
IART
CNMD
ZIMV
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesRvmfjmtnyFpvmjh$182.7 Bil
SYK
Stryker CorpDzspbvkkjYfggz$124.6 Bil
MDT
Medtronic PLCFszkcwsnyHmbnpp$105.2 Bil
BSX
Boston Scientific CorpVpvhcqzbBmlhk$99.0 Bil
DXCM
DexCom IncKplkqhzrKmjw$51.8 Bil
EW
Edwards Lifesciences CorpJbvzyqlxkhGskhnsx$51.7 Bil
ZBH
Zimmer Biomet Holdings IncYlnhhkcpwtGfhdq$24.5 Bil
ALGN
Align Technology IncVdxnvjslGnqcw$22.5 Bil
PHG
Koninklijke Philips NV ADRZhscgbdtdGpdcdtd$18.3 Bil
PODD
Insulet CorpChbnxssnvRvqbb$11.6 Bil

Sponsor Center